SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Matritech (NASDAQ - NMPS)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Patrick Tang who wrote (109)7/12/1996 5:30:00 PM
From: eugenic1   of 849
 
Kudos to you Patrick.
You certainly did call it. Your experience is an asset to this thread.
Please keep the insight coming. Regarding the report, I would not have
a clue. Regarding PR firms, I have had doubts about almost everyone I
have seen, relating to promoting shareholder value. Co's get flamed if
they don't have one, and the one's that do, get flamed because the PR
firms seem to do nada. Everything is great when the prices are up, and
vice versa. I still think Chubb has shown savvy in his moves over the last 8
or 9 months. Urocor, new relationships in Europe, withdrawing offering,
and wording of releases. These may have been with input from the PR
firm as well. We need some strength and a little momentum to help the
cause.
I think the NMP technology is a real winner and earnings will come. I
almost wish I was a Urocor rep...
best returns
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext